Effective treatment of Stage I uterine papillary serous carcinoma with high dose-rate vaginal apex radiation (192Ir) and chemotherapy

International Journal of Radiation Oncology Biology Physics

Volumn 40, Issue 1, 1998, Pages 77-84

  Turner, Bruce C ^a   Knisely, Jonathan P S ^a   Kacinski, Barry M ^a   Haffty, Bruce G ^a   Gumbs, Andrew A ^a   Roberts, Kenneth B ^a   Frank, Alex H ^b   Peschel, Richard E ^a   Rutherford, Thomas J ^a   Edraki, Babak ^a   Kohorn, Ernest I ^a   Chambers, Setsuko K ^a   Schwartz, Peter E ^a   Wilson, Lynn D ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Glens Falls Hospital   (United States)

Author keywords

Brachytherapy; Chemotherapy; Radiation therapy; Uterine cancer; Uterine papillary serous carcinoma

Indexed keywords

CESIUM 137; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; IRIDIUM 192; RADIUM 226;

ABDOMINAL HYSTERECTOMY; ABDOMINAL RADIOTHERAPY; ADULT; AGED; ARTICLE; BEAM THERAPY; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; HUMAN; PAPILLARY CARCINOMA; PRIORITY JOURNAL; SALPINGOOOPHORECTOMY; UTERUS CARCINOMA; VAGINA;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRACHYTHERAPY; CHEMOTHERAPY, ADJUVANT; CYSTADENOCARCINOMA, PAPILLARY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; HYSTERECTOMY; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SALVAGE THERAPY; UTERINE NEOPLASMS;

EID: 0031963440     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(97)00581-6     Document Type: Article

References (43)

1. Ambeler V. M., Kjorstad K. E. Serous papillary carcinoma of the endometrium a histopathological study of 22 cases . Gynecol. Oncol. 39:1990;266-271.
2. Bedwinek J., Galakatos A., Camel M., Kao M., Stokes S., Perez C. Stage I, grade III adenocarcinoma of the endometrium treated with surgery and irradiation. Cancer. 54:(1):1984;40-47.
3. Bergh J., Norberg T., Sjogren S., Lindgen A., Holmberg L. Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant therapy and radiotherapy. Nature Med. 1:(10):1995;1029-1034.
4. Carcangiu M. L., Chambers J. T. Uterine papillary serous carcinoma a study on 108 cases with emphasis on the prognostic significance of associated endometrioid carcinoma, absence of invasion, and concomitant ovarian carcinoma . Gynecol. Oncol. 47:1992;298-305.
5. Carcangiu M. L., Chambers J. T. Early pathologic stage clear cell carcinoma and uterine papillary serous carcinoma of the endometrium comparison of clinicopathologic features and survival . Int. J. Gynecol. Pathol. 14:1995;30-38.
6. Chambers J. T., Merino M., Kohorn E. I., Peschel R. E., Schwartz P. E. Uterine papillary serous carcinoma. Obstet. Gynecol. 69:1987;109-113.
7. Christman J. E., Kapp D. S., Hendrickson M. R., Howes A. E., Ballon S. C. Therapeutic approaches to uterine papillary serous carcinoma a preliminary report . Gynecol. Oncol. 26:1987;228-235.
8. Fitzgerald G., Rosenthal S. Uterine papillary serous carcinoma complete response to combination chemotherapy . Cancer. 56:1985;1023-1024.
9. Frank A. H., Tseng P. C., Haffty B. G., Papadopoulos D. P., Kacinski B. M., Dowling S. W., Carcangiu M. L., Kohorn E. I., Chambers J. T., Chambers S. K., Peschel R. E., Schwartz P. E. Adjuvant whole-abdominal radiation therapy in uterine papillary serous carcinoma. Cancer. 68:1991;1516-1519.
10. Gallion H. H., Van Nagell J. R., Powell D. F., Donaldson E. S., Higgins R. V., Kryscio R. J., Pavlik E. J., Nelson K. Stage I serous papillary carcinoma of the endometrium. Cancer. 63:1989;2224-2228.
11. Gitsch G., Friedlander M. L., Wain G. V., Hacker N. F. Uterine papillary serous carcinoma. Cancer. 75:(9):1995;2239-2243.
12. Goff B. A., Kato D., Schmidt R. A., Ek M., Ferry J. A., Muntz H. C., Cain J. M., Tamimi H. K., Figge D. C., Greer B. E. Uterine papillary serous carcinoma pattern of metastatic spread . Gynecol. Oncol. 54:1994;264-268.
13. Graham J. The value of preoperative or postoperative treatment by radium for carcinoma of the uterine body. Surg. Gynecol. Obstet. 132:1971;855-860.
14. Gumbs, A. A.; Turner, B. C.; Knisely, J. P.; Kacinski, B. M.; Roberts, K. B.; Peschel, R. E.; Haffty, B. G.; Rutherford, T. J.; Edraki, B.; Schwartz, P. E.; Wilson, L. D. Post-operative high dose rate vaginal apex brachytherapy in stage I endometrial adenocarcinoma (Abstr.). Int. J. Radiat. Oncol. Biol. Phys. 36(Supp.)1:327; 1996.
15. Hendrickson M., Martinez A., Ross J., Kempson R., Eifel P. Uterine papillary serous carcinoma. Am. J. Surg. Pathol. 2:1982;93-108.
16. Hirai Y., Kawaguchi T., Hasumi K., Kitagawa T., Noda T. Establishment and characterization of human cell lines from a serous papillary adenocarcinoma of the endometrium. Gynecol. Oncol. 54:1994;184-195.
17. Jeffrey J. J., Krepart G. V., Lotocki R. J. Papillary serous adenocarcinoma of the endometrium. Obstet. Gynecol. 67:1986;670-674.
18. Khalifa M. A., Mannel R. S., Haraway S. D., Walker J., Min K. Expression of EGFR, HER-2/neu, P53, and PCNA in endometroid, serous papillary, and clear cell endometrial adenocarcinomas. Gynecol. Oncol. 53:1994;84-92.
19. Konski A. A., Domenico D., Irving D., Tyrkus M., Neisler J., Phibbs G., Mah J., Eggleston W. Clinicopathologic correlation of DNA flow cytometric content analysis, surgical staging, and estrogen/progesterone receptor status in endometrial adenocarcinoma. Am. J. Clin. Oncol. 19:(2):1996;164-168.
20. Levenback C., Burke T. W., Silva E., Morris M., Gershenson D. M., Kavanagh J. J., Wharton J. Uterine papillary serous carcinoma treated with cisplatinum, doxorubicin, and cyclophosphamide. Gynecol. Oncol. 46:1992;317-321.
21. LiVolsi V. A. Adenocarcinoma of the endometrium with psammoma bodies. Obstet. Gynecol. 50:1977;725-728.
22. Mallipeddi P., Kapp D. S., Teng N. H. Long-term survival with adjuvant whole abdominopelvic irradiation for uterine papillary serous carcinoma. Cancer. 71:1993;3076-3081.
23. Mandell L., Nori D., Anderson L., Hilaris B. Postoperative vaginal radiation in endometrial cancer using a remote afterloading technique. Int. J. Radiat. Oncol. Biol. Phys. 11:1985;473-478.
24. Nori D., Hilaris B., Tome M., Lewis J. L., Birnbaum S., Fuks Z. Combined surgery and radiation in endometrial carcinoma an analysis of prognostic factors . Int. J. Radiat. Oncol. Biol. Phys. 13:1987;489-497.
25. Nori D., Merimsky O., Batata M., Caputa T. Postoperative high dose-rate intravaginal brachytherapy combined with external irradiation for early stage endometrial cancer a long-term follow-up . Int. J. Radiat. Cncol. Biol. Phys. 30:1994;831-837.
26. Nordstrom B., Strang P., Lindgren A., Bergstrom R., Tribukait B. Endometrial carcinoma the prognostic impact of papillary serous carcinoma in relation to nuclear grade, DNA ploidy, and p53 expression . Anti-Cancer Res. 16:1996;899-904.
27. Noyes W. R., Bastin K., Edwards S. A., Buchler D. A., Stitt J. A., Thomadsen B. R., Fowler J. F., Kinsella T. J. Postoperative vaginal cuff irradiation using high dose rate remote afterloading a phase II clinical protocol . Int. J. Radiat. Oncol. Biol. Phys. 32:1995;1439-1443.
28. O'Hanlan K. A., Levine P. A., Harbatkin D., Feiner C., Goldberg G. L., Jones J. G., Rodriguez L. Virulence of papillary endometrial carcinoma. Gynecol. Oncol. 37:1990;112-119.
29. Perez C. A., Grigsby P. W. Irradiation in the management of carcinoma of the endometrium a review . Endo. Hypertherm. Oncol. 11:1995;67-95.
30. Peschel R. E., Healey G. A., Smith R. J., Haffty B., Papadopoulos D., Chambers J. T., Chambers S. K., Kohorn E. I., Schwartz P. E. High dose rate afterloading for endometrial cancer. Endo. Hypertherm. Oncol. 5:1989;209-214.
31. Price F. V., Chambers S. K., Carcangiu M. L., Kohorn E. I., Schwartz P. E., Chambers J. T. Intravenous cisplatin, doxorubicin, cyclophosphamide in the treatment of uterine papillary serous carcinoma (UPSC). Gynecol. Oncol. 51:1993;383-389.
32. Ramirez-Gonzales C. E., Adamsons K., Mangual-Vasquez T. Y., Wallach R. C. Papillary adenocarcinoma in the endometrium. Obstet. Gynecol. 70:1987;21-215.
33. Reed M., Taylor R., Arroyo G., Parker M., Geradts J., Birrer M. Analysis of p53, p16, retinoblastoma, and Ki-ras abnormalities in papillary serous carcinoma of the endometrium (Abst.). Proc. Am. Assoc. Cancer Res. 37:1996;242.
34. Rosenberg P., Risberg B., Askmalm L., Simonsen E. The prognosis in early endometrial carcinoma. Acta Obstet. Gynecol. Scand. 68:1989;157-163.
35. Rosenberg P., Blom R., Hogberg T., Simonsen E. Death rate and recurrence pattern among 841 clinical stage I endometrial cancer patients with special reference to uterine papillary serous carcinoma. Gynecol. Oncol. 51:1993;311-315.
36. Shepard J. H. Revised FIGO staging for gynaecological cancer. Br. J. Obstet. Gynecol. 96:1989;889-892.
37. Sherman M. E., Bitterman P., Rosenshei N. B., Delgado G., Kurman R. J. Uterine serous carcinoma. Am. J. Surg. Pathol. 16:(6):1992;600-610.
38. Sorbe B., Smeds A. C. Postoperative vaginal irradiation with high dose rate afterloading technique in endometrial carcinoma stage I. Int. J. Radiat. Oncol. Biol. Phys. 18:1990;305-314.
39. Stokes S., Bedwinek J., Kao M., Camel H. M., Perez C. A. Treatment of stage I adenocarcinoma of the endometrium by hysterectomy and adjuvant irradiation a retrospective analysis of 304 patients . Int. J. Radiat. Oncol. Biol. Phys. 12:1986;339-344.
40. Sutton G. P., Brill L., Michael H., Stehman F. B., Ehrlich C. E. Malignant papillary lesions of the endometrium. Gynecol. Oncol. 27:1987;294-304.
41. Turner B. C., Haffty B. G., Naryanan L., Yuan J., Havre P. A., Gumbs A. A., Kaplan L., Burgaud J. L., Carter D., Baserga R., Glazer P. M. Insulin-like growth factor-1 receptor overexpression mediates cellular radioresistance and local breast cancer recurrence after lumpectomy and radiation. Cancer Res. 57:1997;3079-3083.
42. Ward B. G., Wright R. G., Free K. Papillary carcinomas of the endometrium. Gynecol. Oncol. 39:1990;347-351.
43. Zheng W., Cao P., Zheng M., Kramer E., Godwin T. A. p53 overexpression and bcl-2 persistence in endometrial carcinoma comparison of papillary serous and endometroid subtypes . Gynecol. Oncol. 61:1996;167-174.